Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial

被引：0
|
作者：
Piccini, Jonathan P. [1 ]
Garg, Jyotsna [2 ]
Patel, Manesh R. [1 ]
Lokhnygina, Yuliya [3 ]
Goodman, Shaun G. [4 ,5 ]
Becker, Richard C. [1 ]
Berkowitz, Scott D. [6 ]
Breithardt, Gunter [7 ]
Hacke, Werner [8 ]
Halperin, Jonathan L. [9 ]
Hankey, Graeme I. [10 ,11 ]
Nessel, Christopher C. [12 ]
Mahaffey, Kenneth W. [1 ]
Singer, Daniel E. [13 ,14 ]
Califf, Robert M. [15 ]
Fox, Keith A. [16 ,17 ]
机构：
[1] Duke Clin Rsch Inst, Dept Med, Div Cardiol, Durham, NC USA
[2] Duke Clin Rsch Inst, Stat Grp, Durham, NC USA
[3] Duke Clin Rsch Inst, Dept Biostat & Bioinformat, Durham, NC USA
[4] Univ Toronto, St Michaels Hosp, Canadian Heart Rsch Cntr, Toronto, ON, Canada
[5] Terrence Donnelly Heart Cntr, Toronto, ON, Canada
[6] Bayer HealthCare Pharmaceut, Global Therapeut Rsch, Cardiovasc Pharmacol, Montville, NJ USA
[7] Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany
[8] Heidelberg Univ, Dept Neurol, Heidelberg, Germany
[9] Mt Sinai, Icahn Sch Med, Mt Sinai Med Cntr, Cardiovasc Inst, New York, NY USA
[10] Univ Western Australia, Sch Med & Pharmacol, Dept Neurol, Perth, WA 6009, Australia
[11] Royal Perth Hosp, Stroke Unit, Perth, WA 6001, Australia
[12] Janssen Rsch & Dev, Clin Rsch, Raritan, NJ USA
[13] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[14] Harvard Univ, Sch Med, Boston, MA USA
[15] Duke Translat Med Inst, Dept Med, Div Cardiol, Durham, NC USA
[16] Univ Edinburgh, Cntr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[17] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Atrial fibrillation; Stroke; Risk factors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15879
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Prothrombin Complex Concentrate in Patients Treated with Rivaroxaban or Apixaban Compared to Warfarin Presenting with Major Bleeding
    Arachchillage, Deepa Jayakody
    Alavian, Sharon
    Griffin, Jessica
    Gurung, Kamala
    Syzdlo, Richard
    Karawitage, Nilanthi
    Laffan, Michael
    BLOOD, 2018, 132
  • [42] Major bleeding among patients with atrial fibrillation treated with rivaroxaban or warfarin in Sweden. Interim results from an on-going post-authorization study
    Friberg, L.
    EUROPEAN HEART JOURNAL, 2016, 37 : 402 - 403
  • [43] Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding
    Arachchillage, Deepa R. J.
    Alavian, Sharon
    Griffin, Jessica
    Gurung, Kamala
    Szydlo, Richard
    Karawitage, Nilanthi
    Laffan, Mike
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (05) : 808 - 816
  • [44] In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events
    Gue, Ying X.
    Lip, Gregory Y. H.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (04) : JC43 - JC43
  • [45] MANAGEMENT AND OUTCOMES OF MAJOR BLEEDING EVENTS IN PATIENTS TAKING DABIGATRAN OR WARFARIN IN CLINICAL PRACTICE
    Smythe, Maureen A.
    Conger, Elizabeth A.
    Hoffman, Janet L.
    Forman, Michael J.
    Koerber, John M.
    Saboo, Shaun A.
    Dezia, Alen L.
    Pillen, Heidi A.
    Qasem, Lina Y.
    Priziola, Jennifer L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E70 - E70
  • [46] Rivaroxaban: from ROCKET-AF trial to routine practice in Spain Foreword
    Escobar Cervantes, Carlos
    FUTURE CARDIOLOGY, 2018, 14 (03) : 1 - 2
  • [47] A nomogram for predicting major gastrointestinal bleeding in patients treated with rivaroxaban
    Cao, Haiyan
    Xu, Hongyan
    Zhu, Min
    Chu, Xinglin
    Zhang, Zhihuan
    Dong, Yongqi
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (11) : 1228 - 1236
  • [48] Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial
    Vemulapalli, Sreekanth
    Hellkamp, Anne S.
    Jones, W. Schuyler
    Piccini, Jonathan P.
    Mahaffey, Kenneth W.
    Becker, Richard C.
    Hankey, Graeme J.
    Berkowitz, Scott D.
    Nessel, Christopher C.
    Breithardt, Guenter
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    AMERICAN HEART JOURNAL, 2016, 178 : 74 - 84
  • [49] REAL-WORLD VERSUS RANDOMIZED TRIAL OUTCOMES IN SIMILAR POPULATIONS OF RIVAROXABAN-TREATED PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN ROCKET AF AND XANTUS
    Camm, A. John
    Amarenco, Pierre
    Haas, Sylvia
    Hess, Susanne
    Kirchhof, Paulus
    Kuhls, Silvia
    Lambelet, Marc
    van Eickels, Martin
    Turpie, Alexander
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 438 - 438
  • [50] Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF
    Uchiyama, Shinichiro
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iekushi, Kazuma
    Yamanaka, Satoshi
    Tajiri, Masahiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (05): : 1142 - 1147
12345